FindTrial
Sign In

Effect of tandospirone on cognition and social function in schizophrenia

Effect of tandospirone on cognition and social function in schizophrenia - Cognition and tandospirone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006685
Enrollment
80
Registered
2011-11-07
Start date
2011-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Tandospirone added Tandospirone not added

Sponsors

Department of Neuropsychiatry, University of Toyama
Lead Sponsor
National Center of Neurology and Psychiatry St Marianna Medical University Kanazawa Medical University Osaka University Jikei Hospital Okayama University Hizen Psychiatric Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: meets DSM-IV criteria for schizophrenia or schizoaffective disorder good responder to antipsychotic treatment PANSS score 70 or less Provides written informed consent

Exclusion criteria

Exclusion criteria: 1) Suicide attempt within 6 months before entry 2) Treated with a depot antipsychotic 3) Prescribed anticholinergic drugs and/or tricyclic antidepressants 4)Dependence on alcohol and/or illicit drugs 5) past history of head injury and/or seizure 6) IQ less than 75 7) pregnant 8) BACS and/or UPSA administered within past 6 months

Design outcomes

Primary

MeasureTime frame
Schizophrenia Cognition Rating Scale (SCoRS)—

Secondary

MeasureTime frame
UCSD Performance-based Skills Assessment-Brief (UPSA)—

Countries

Japan

Contacts

Public ContactNoriko Yamada

University of Toyama Department of Neuropsychiatry

tomikisumiyoshi840@hotmail.com076-434-7323

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026